These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 241000

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Ergotamine and methysergide as serotonin partial agonists in migraine.
    Fanciullacci M, Granchi G, Sicuteri F.
    Headache; 1976 Nov; 16(5):226-31. PubMed ID: 977328
    [No Abstract] [Full Text] [Related]

  • 43. Fibrotic disorders associated with methysergide therapy for headache.
    Graham JR, Suby HI, LeCompte PR, Sadowsky NL.
    N Engl J Med; 1966 Feb 17; 274(7):359-68. PubMed ID: 5903120
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Ergotamine: its use in the treatment of migraine and its complications.
    Saxena VK, De Deyn PP.
    Acta Neurol (Napoli); 1992 Apr 17; 14(2):140-6. PubMed ID: 1329442
    [Abstract] [Full Text] [Related]

  • 48. Drugs for migraine.
    Med Lett Drugs Ther; 1976 Jun 18; 18(13):55-6. PubMed ID: 934019
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Treatment of migraine and other vasomotoric headaches using Migrexa].
    Schleip I, Scheller H.
    Munch Med Wochenschr; 1969 Jan 31; 111(5):258-61. PubMed ID: 4182057
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Headache and migraine.
    Ziegler DK.
    Curr Opin Neurol Neurosurg; 1992 Apr 31; 5(2):235-9. PubMed ID: 1320435
    [Abstract] [Full Text] [Related]

  • 53. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
    Scott AK.
    Clin Neuropharmacol; 1992 Aug 31; 15(4):289-96. PubMed ID: 1516074
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Effects of antimigraine drugs on retinal spreading depression.
    Wiedemann M, de Lima VM, Hanke W.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 31; 353(5):552-6. PubMed ID: 8740149
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Symptomatic and prophylactic treatment of migraine and tension-type headache.
    Schulman EA, Silberstein SD.
    Neurology; 1992 Mar 31; 42(3 Suppl 2):16-21. PubMed ID: 1557187
    [Abstract] [Full Text] [Related]

  • 58. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR, Smith SW, Moore J, Biros M.
    Am J Emerg Med; 2007 Jan 31; 25(1):60-4. PubMed ID: 17157685
    [Abstract] [Full Text] [Related]

  • 59. Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage.
    Richter F, Mikulik O, Ebersberger A, Schaible HG.
    J Cereb Blood Flow Metab; 2005 Sep 31; 25(9):1225-35. PubMed ID: 15829916
    [Abstract] [Full Text] [Related]

  • 60. Headache: a biopsychological perspective.
    Bakal DA.
    Psychol Bull; 1975 May 31; 82(3):369-82. PubMed ID: 238255
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.